These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 11095379)

  • 21. Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice?
    Candelli M; Papa A; Nista EC; Danese S; Armuzzi A; Bartolozzi F; Tondi P; Ojetti V; Gasbarrini G; Gasbarrini A
    Hepatogastroenterology; 2003; 50(51):718-20. PubMed ID: 12828069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defective IL-10 production in severe phenotypes of Crohn's disease.
    Correa I; Veny M; Esteller M; Piqué JM; Yagüe J; Panés J; Salas A
    J Leukoc Biol; 2009 May; 85(5):896-903. PubMed ID: 19237638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Crohn's regional enteritis. Etiological viewpoints].
    Riemann JF; Demling L
    Dtsch Med Wochenschr; 1979 Jun; 104(22):787-9. PubMed ID: 456250
    [No Abstract]   [Full Text] [Related]  

  • 24. Crohn's disease: an important differential diagnosis of granulomatous skin diseases.
    Eames T; Landthaler M; Karrer S
    Eur J Dermatol; 2009; 19(4):360-4. PubMed ID: 19443301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dyspeptic macrophage 30 years later: an update in the pathogenesis of Crohn's disease.
    Caprilli R; Frieri G
    Dig Liver Dis; 2009 Feb; 41(2):166-8. PubMed ID: 19026604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastatic Crohn's disease in a child.
    Oskay T; Aykol N; Sahillioğlu M
    Clin Exp Dermatol; 2005 Jul; 30(4):358-60. PubMed ID: 15953068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Capsule endoscopy findings in patients with suspected Crohn's disease and biochemical markers of inflammation.
    De Bona M; Bellumat A; Cian E; Valiante F; Moschini A; De Boni M
    Dig Liver Dis; 2006 May; 38(5):331-5. PubMed ID: 16569524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD14 expression on monocytes and soluble CD14 plasma levels in correlation to the promotor polymorphism of the endotoxin receptor CD14 gene in patients with inactive Crohn's disease.
    Griga T; Klein W; Epplen JT; Hebler U; Stachon A; May B
    Hepatogastroenterology; 2005; 52(63):808-11. PubMed ID: 15966209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-time PCR quantification analysis of five mucosal transcripts in patients with Crohn's disease.
    Eriksson A; Jennische E; Flach CF; Jorge A; Lange S
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):290-6. PubMed ID: 18334872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphism in IgG Fc receptor gene FCGR3A and response to infliximab in Crohn's disease: a subanalysis of the ACCENT I study.
    Louis EJ; Watier HE; Schreiber S; Hampe J; Taillard F; Olson A; Thorne N; Zhang H; Colombel JF
    Pharmacogenet Genomics; 2006 Dec; 16(12):911-4. PubMed ID: 17108815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Crohn's disease. Immunological aspects of the disease (author's transl)].
    Richter J; Bitter J; Zuvacová J; Král V; Simkovicová O
    Cesk Gastroenterol Vyz; 1981 Jul; 35(4):145-50. PubMed ID: 7261087
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course.
    Kim BC; Park S; Han J; Kim JH; Kim TI; Kim WH
    Dig Liver Dis; 2007 Jul; 39(7):610-6. PubMed ID: 17531556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered CD44 variant 6 expression in FIGO stage IB cervical carcinoma.
    Ayhan A; Baykal C; Al A; Ayhan A
    Gynecol Oncol; 2001 Dec; 83(3):569-74. PubMed ID: 11733974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-Saccharomyces cerevisiae antibodies in patients with Crohn's disease].
    Barta Z; Csípö I; Antal-Szalmás P; Sipka S; Szabó G; Szegedi G
    Orv Hetil; 2001 Oct; 142(42):2303-7. PubMed ID: 11760647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional characterisation of decoy receptor 3 in Crohn's disease.
    Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
    Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma.
    Costa S; Terzano P; Bovicelli A; Martoni A; Angelelli B; Santini D; Ceccarelli C; Lipponen P; Erzén M; Syrjänen S; Syrjänen K
    Gynecol Oncol; 2001 Jan; 80(1):67-73. PubMed ID: 11136572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Animal transmission models.
    Sachar DB
    Mt Sinai J Med; 1983; 50(2):166-70. PubMed ID: 6602284
    [No Abstract]   [Full Text] [Related]  

  • 38. CD44 and its role in inflammation and inflammatory diseases.
    Johnson P; Ruffell B
    Inflamm Allergy Drug Targets; 2009 Jul; 8(3):208-20. PubMed ID: 19601881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD44 isoform expression on colonic epithelium mediates lamina propria lymphocyte adhesion and is controlled by Th1 and Th2 cytokines.
    Macdonald DC; Leir SH; Brooks C; Sanders E; Lackie P; Rosenberg W
    Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1101-10. PubMed ID: 14501619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional activity of murine CD44 variant isoforms in allergic and delayed type hypersensitivity.
    Wittig B; Seiter S; Föger N; Schwärzler C; Günthert U; Zöller M
    Immunol Lett; 1997 Jun; 57(1-3):217-23. PubMed ID: 9232455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.